StonvexLoading…
StonvexStonvexStonvexCore line items from CBIO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 |
|---|---|---|
Revenue | $10.84M | $0.00 |
Operating Income | $-152.63M | $-17.19M |
Net Income | $-153.94M | $-17.87M |
EPS (Diluted) | Not available | $-0.59 |
Total Assets | $240.29M | $35.62M |
Total Liabilities | $37.28M | $47.10M |
Cash & Equivalents | $213.19M | $34.77M |
Free Cash Flow OCF − CapEx | $-72.45M | $-6.27M |
Shares Outstanding | 27.56M | 1.02M |